These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37741448)

  • 1. The Relationship Between Pharmaceutical Innovation and Cancer Mortality in Spain, From 1999 to 2016.
    Lichtenberg FR
    Value Health; 2023 Dec; 26(12):1711-1720. PubMed ID: 37741448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pharmaceutical innovation on longevity: Evidence from the U.S. and 26 high-income countries.
    Lichtenberg FR
    Econ Hum Biol; 2022 Aug; 46():101124. PubMed ID: 35344806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of pharmaceutical innovation on premature mortality, cancer mortality, and hospitalization in Slovenia, 1997-2010.
    Lichtenberg FR
    Appl Health Econ Health Policy; 2015 Apr; 13(2):207-22. PubMed ID: 25564200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995-2012.
    Lichtenberg FR
    Eur J Health Econ; 2016 Sep; 17(7):833-54. PubMed ID: 26342826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000-2011.
    Lichtenberg FR
    Int J Health Econ Manag; 2015 Sep; 15(3):339-359. PubMed ID: 27878681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of pharmaceutical innovation on the longevity and hospitalization of New Zealand cancer patients, 1998-2017.
    Lichtenberg FR
    Expert Rev Pharmacoecon Outcomes Res; 2021 Jun; 21(3):476-477. PubMed ID: 33412958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical innovation and the longevity of Australians: a first look.
    Lichtenberg FR; Duflos G
    Adv Health Econ Health Serv Res; 2008; 19():95-117. PubMed ID: 19548515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Pharmaceutical Innovation on Cancer Mortality in Belgium, 2004-2012.
    Lichtenberg FR
    Forum Health Econ Policy; 2016 Sep; 20(1):. PubMed ID: 31419903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999-2010.
    Lichtenberg FR; Tatar M; Çalışkan Z
    Health Policy; 2014 Sep; 117(3):361-73. PubMed ID: 24996837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of pharmaceutical innovation on the burden of disease in Ireland, 2000-2015.
    Lichtenberg FR
    J Public Health (Oxf); 2020 Nov; 42(4):816-827. PubMed ID: 31927585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000-2009.
    Lichtenberg FR
    Econ Hum Biol; 2014 Mar; 13():107-27. PubMed ID: 23664114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files.
    Lichtenberg FR
    Forum Health Econ Policy; 2013 Jan; 16(1):1-33. PubMed ID: 31419866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adoption of pharmaceutical innovation and its impact on the treatment costs for Alzheimer's disease in Taiwan.
    Lo TF; Hsieh CR
    J Ment Health Policy Econ; 2014 Sep; 17(3):107-17. PubMed ID: 25543114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoption of pharmaceutical innovation and the growth of drug expenditure in Taiwan: is it cost effective?
    Hsieh CR; Sloan FA
    Value Health; 2008; 11(2):334-44. PubMed ID: 18380646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Has pharmaceutical innovation reduced the average cost of U.S. health care episodes?
    Lichtenberg FR
    Int J Health Econ Manag; 2024 Mar; 24(1):1-31. PubMed ID: 37940731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Drugs in Clinical Practice and the Associated Cost of Cancer Treatment in Adult Patients with Solid Tumors: A 10-Year Retrospective Cohort Study.
    Carreras MJ; Tomás-Guillén E; Farriols A; Renedo-Miró B; Valdivia C; Vidal J; Saura C; Carles J; Felip E; Gorgas MQ; Tabernero J; Monterde J
    Curr Oncol; 2023 Aug; 30(9):7984-8004. PubMed ID: 37754495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Number of drugs provided by the Pharmaceutical Benefits Scheme and mortality and hospital utilization in Australia, 2002-2019.
    Lichtenberg FR
    SSM Popul Health; 2023 Dec; 24():101514. PubMed ID: 37731531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methuselah's medicine: pharmaceutical innovation and mortality in the United States, 1960-2000.
    Schnittker J; Karandinos G
    Soc Sci Med; 2010 Apr; 70(7):961-8. PubMed ID: 20100632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical expenditures as a correlate of population health in industrialized nations.
    Liu L; Cline RR; Schondelmeyer SW; Schommer JC
    Ann Pharmacother; 2008 Mar; 42(3):368-74. PubMed ID: 18272699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous technological change in medicine and its impact on healthcare costs: evidence from the pharmaceutical market in Taiwan.
    Hsieh CR; Liu YM; Chang CL
    Eur J Health Econ; 2013 Apr; 14(2):287-95. PubMed ID: 22200844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.